Evidence map›Paper›PMID 24151175›Full record

ArticleJournal of biomedical materials research. Part A2014

Crosslinking of collagen scaffolds promotes blood and lymphatic vascular stability.

Kelvin L S Chan, Aimal H Khankhel, Rebecca L Thompson, Brent J Coisman, Keith H K Wong, James G Truslow, Joe Tien

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Biomaterials in the clinical treatment of lymphedema-a systematic review.Journal of vascular surgery. Venous and lymphatic disorders · 2024
    Pooled it
  2. Review
  3. Review
  4. Understanding the Lymphatic System: Tissue-on-Chip Modeling.Annual review of biomedical engineering · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Collagen- and hyaluronic acid-based hydrogels and their biomedical applications.Materials science & engineering. R, Reports : a review journal · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Microfluidic Biomaterials.Advanced healthcare materials · 2021
    Review
  16. Review
  17. Engineered Collagen Matrices.Bioengineering (Basel, Switzerland) · 2020
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kelvin L S Chan *Department of Biomedical Engineering, Boston University, 44 Cummington Mall, Boston, MA 02215.
Aimal H Khankhel *Department of Biomedical Engineering, Boston University, 44 Cummington Mall, Boston, MA 02215.
Rebecca L ThompsonDepartment of Biomedical Engineering, Boston University, 44 Cummington Mall, Boston, MA 02215.
Brent J CoismanDepartment of Biomedical Engineering, Boston University, 44 Cummington Mall, Boston, MA 02215.
Keith H K WongDepartment of Biomedical Engineering, Boston University, 44 Cummington Mall, Boston, MA 02215.
James G TruslowDepartment of Biomedical Engineering, Boston University, 44 Cummington Mall, Boston, MA 02215.
Joe TienDepartment of Biomedical Engineering, Boston University, 44 Cummington Mall, Boston, MA 02215.

Funding

Engineering Functional Lymphatic Networks in VitroR21HL092335 · NHLBI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI TIEN, JOE Y · 2009 to 2010
$447k
NHLBI NIH HHS HL092335NHLBI NIH HHS R21 HL092335
6 · The paper itself

Abstract

The low stiffness of reconstituted collagen hydrogels has limited their use as scaffolds for engineering implantable tissues. Although chemical crosslinking has been used to stiffen collagen and protect it against enzymatic degradation in vivo, it remains unclear how crosslinking alters the vascularization of collagen hydrogels. In this study, we examine how the crosslinking agents genipin and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide alter vascular stability and function in microfluidic type I collagen gels in vitro. Under moderate perfusion (∼10 dyn/cm(2) shear stress), tubes of blood endothelial cells (ECs) exhibited indistinguishable stability and barrier function in untreated and crosslinked scaffolds. Surprisingly, under low perfusion (∼5 dyn/cm(2) shear stress) or nearly zero transmural pressure, microvessels in crosslinked scaffolds remained stable, while those in untreated gels rapidly delaminated and became poorly perfused. Similarly, tubes of lymphatic ECs under intermittent flow were more stable in crosslinked gels than in untreated ones. These effects correlated well with the degree of mechanical stiffening, as predicted by analysis of fracture energies at the cell-scaffold interface. This work demonstrates that crosslinking of collagen scaffolds does not hinder normal EC physiology; instead, crosslinked scaffolds promote vascular stability. Thus, routine crosslinking of scaffolds may assist in vascularization of engineered tissues.

Indexed as

Biocompatible MaterialsBioprosthesisCell LineCollagenCross-Linking ReagentsEndothelial CellsEthyldimethylaminopropyl CarbodiimideHumansIridoidsMaterials TestingStress, MechanicalTissue ScaffoldsBiocompatible MaterialsCollagenCross-Linking ReagentsEthyldimethylaminopropyl CarbodiimidegenipinIridoidsextracellular matrixmicrovascular tissue engineeringperfusionstiffnessvascular physiology

Identifiers

PMID24151175
PMCPMC3995898

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.